Published February 14, 2025 | Version v1
Journal article Open

The importance of early screening in preventing chronic diseases

Authors/Creators

  • 1. Dagestan State Medical University,.Lenin street 1, 367005, Dagestan,
  • 2. Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8, building 2, Trubetskaya St., Moscow 119048, Russia
  • 3. Federal State Autonomous Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation,1 Ostrovityanova, Moscow, 117513, Russia
  • 4. Federal State Budgetary Educational Institution of Higher Education "Tyumen State Medical University" of the Ministry of Healthcare of the Russian Federation, Odesskaya St., 54, Tyumen, Tyumen Region, 625023, Russia
  • 5. Federal State Autonomous Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation 1 Ostrovityanova, Moscow,117513, Russia
  • 6. Saint petersburg state pediatric medical university, 194100, Saint Petersburg, Litovskaya 2, Russia,
  • 7. Federal State Budgetary Educational Institution of Higher Education «Astrakhan State Medical University",414000, Astrakhan, Bakinskaya str. 121

Description

Abstract: The article explores in detail the role of early screening as an effective tool for the prevention of chronic diseases. The importance of timely detection of pathological changes and risk factors at early stages, such as high cholesterol, hypertension, overweight, hereditary predisposition, as well as the influence of such factors on the development of cardiovascular diseases, diabetes mellitus, oncological and pulmonary pathologies is considered.

The authors pay special attention to the evidence base confirming that early diagnosis contributes to a significant reduction in morbidity and mortality, improves the effectiveness of treatment and minimises the need for costly and complex medical interventions. They also emphasise the importance of integrating screening measures into the health care system and highlight the need to raise public awareness of the benefits of preventive screening.

The article analyses examples of successful screening programmes, their impact on public health and the economic benefits of implementation. Barriers related to insufficient accessibility of health services, inadequate population coverage and low awareness are discussed. Recommendations for improving screening programmes are offered, including the introduction of modern technology, personalised approaches and the expansion of educational initiatives among health care providers and the public. Thus, the paper emphasises the key role of early screening in shaping chronic disease prevention strategies and improving people's quality of life.

Files

8 The importance of early screening.pdf

Files (323.7 kB)

Name Size Download all
md5:2d571097b0d2d42febc31085a907dde9
323.7 kB Preview Download

Additional details

References

  • 1. Chen SC, Hwang SJ, Tsai JC, et al. Early nephrology referral is associated with prolonged survival in hemodialysis patients even after exclusion of lead-time bias. Am J Med Sci. 2010;339(2):123-126.
  • Abraham JM. Employer wellness programs—a work in progress. JAMA. 2019;321(15):1462-1463
  • 3. Song Z, Baicker K. Effect of a workplace wellness program on employee health and economic outcomes: a randomized clinical trial [erratum in JAMA. 2019;321(18):1830.
  • 4. Teliti M, Cogni G, Sacchi L, et al. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients. Diab Vasc Dis Res. 2018;15(5):424-432.
  • Maghbooli Z, Pasalar P, Keshtkar A, Farzadfar F, Larijani B. Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord. 2014;13:55.
  • Sim JJ, Rutkowski MP, Selevan DC, et al. Kaiser Permanente creatinine safety program: a mechanism to ensure widespread detection and care for chronic kidney disease. Am J Med. 2015;128(11):1204-1211.
  • 7. Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare population. J Am Soc Nephrol. 2013;24(9):1478-1483.
  • Levin TR, Corley DA, Jensen CD, et al. Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population. Gastroenterology. 2018;155(5):1383-1391.e5.
  • 9. Cyhaniuk A, Coombes ME. Longitudinal adherence to colorectal cancer screening guidelines. Am J Manag Care. 2016;22(2):105-111.
  • 10. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. 2016;315(23):2595-2609.
  • 11. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F.Fertil Steril. 2017 Dec;108(6):1078-1084.
  • 12. Ramaswamy G, Chinnakali P, Selvaraju S, Nair D, Thekkur P, Selvaraj K, Shivashankar R, Singh AR, Vrushabhendra HN.Diabetes Metab Syndr. 2019 Jan-Feb;13(1):866-872.
  • 13. Zand A, Ibrahim K, Patham B.Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):289-297.
  • Manns B, Hemmelgarn B, Tonelli M, et al; Alberta Kidney Disease Network. Population based screening for chronic kidney disease: cost effectiveness study. BMJ. 2010;341:c5869.
  • American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-928.
  • Shiffman D, Tong CH, Rowland CM, Devlin JJ, Meigs JB, McPhaul MJ. Elevated hemoglobin A1c is associated with incident diabetes within 4 years among normoglycemic, working-age individuals in an employee wellness program. Diabetes Care. 2018;41(6):e99-e100.
  • 17. Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med. 2013;45(3):253-261.
  • Thomsen S. Delayed progression to dialysis with early and intensive management of predialysis chronic kidney disease: a case-based approach. Case Rep Nephrol Urol. 2013;3(1):74-86.
  • 19. Dall TM, Yang W, Halder P, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care. 2014;37(12):3172-3179.
  • 20. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91(5):434-437.
  • Mosyagin I.G. The role and place marine medicine // Marine Medicine. 2023. Vol. 9, № 3. С. 7-12, doi: http://dx.doi.org/10.22328/2413-5747-2023-9-3-7-12
  • 22. Kotovskaya S.V., Boyko I.M., Mosyagin I.G., Khokhrina A.I. The role of a family and a close environment in the formation of the resilience of the extreme activity subjects: cross-sectional study. Marine medicine. 2022. Vol. 9, No. 2. P. 98-104, doi: https://dx.doi.org/10.22328/2413-5747-2023-9-2-98-104
  • 23. Masko E.V., Mosyagin I.G., Boyko I.M. Seasonal dynamics of the functional state of the nervous system of military-age skiers according to visual-motor reaction data // Marine medicine. 2022. Vol. 8, No. 3. P. 70–76, DOI: http://dx.doi.org/10.22328/2413-5747-2022-8-3-70-76.
  • 24. Masko E.V., Mosyagin I.G., Boyko I.M. Bioelectric activity of a brain and cerebral hemodynamics in skiers of military age over seasons of the year // Marine medicine. 2022. Vol. 8, No. 4. P. 72–77, DOI: http://dx.doi.org/10.22328/2413- 5747-2022-8-4-72-77.
  • 25. Evdokimov V.I., Mosyagin I.G., Sivashchenko Р.P. Primary disease incidence with officers of the Russian aerospace forces and navy (2015–2020) // Marine Medicine. Vol. 8, No. 2. Р. 38–47. DOI: http://dx.doi.org/10.22328/2413- 5747-2022-8-2-38-47